Viewing Study NCT03941132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2025-12-27 @ 12:31 PM
Study NCT ID: NCT03941132
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-24
First Post: 2019-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
Sponsor: University of British Columbia
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 1 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T1D View
None Ustekinumab View
None new-onset View
None diabetes View